Association of Adolescent Hypertension With Future End-stage Renal Disease. 2019

Adi Leiba, and Boris Fishman, and Gilad Twig, and David Gilad, and Estela Derazne, and Ari Shamiss, and Tamar Shohat, and Ofir Ron, and Ehud Grossman
Division of Nephrology and Hypertension, Assuta Ashdod Academic Medical Center, Ben Gurion University, Beer Sheva, Israel.

Hypertension is a leading risk factor of cardiovascular morbidity and mortality. The role of nonmalignant hypertension as the sole initiating factor of end-stage renal disease (ESRD) in non-African American populations has recently been questioned. To investigate the association between hypertension and future ESRD in otherwise healthy adolescents. This retrospective cohort study examined the data of 16- to 19-year-old healthy candidates for military service in the Israel Defense Forces between January 1, 1967, and December 31, 2013. Data were obtained from the central conscription registry of the Israel Defense Forces and the ESRD registry of the Israel Ministry of Health. Participants underwent a comprehensive medical assessment prior to their military service. Individuals with evidence of renal damage or kidney-related risk factors were excluded. The data analysis was conducted from February 12, 2017, to October 16, 2018. End-stage renal disease as recorded by the Israeli ESRD registry, including hemodialysis, peritoneal dialysis, renal transplant diagnosed between January 1, 1990, and December 31, 2014. The cohort included 2 658 238 adolescents (1 596 709 [60.1%] male with a mean [SD] age of 17.4 [0.5] years), of whom 7997 (0.3%) had an established hypertension diagnosis. Half of the individuals in the hypertensive group were overweight (1559 [20.1%]) or obese (2243 [28.9%]), and most (7235 [90.5%]) were male. During a median follow-up of 19.6 years (52 287 945 person-years), 2189 individuals developed ESRD, with an incidence rate of 3.9 per 100 000 person-years. Adolescent hypertension was found to be associated with future ESRD (crude hazard ratio [HR], 5.07; 95% CI, 3.73-6.88). In a multivariable model adjusted for sex, age, years of education, body mass index, and other sociodemographic variables, the HR was 1.98 (95% CI, 1.42-2.77). When excluding participants with severe hypertension, the association with ESRD remained statistically significant (HR, 1.93; 95% CI, 1.37-2.70). In the subanalysis of nonoverweight adolescents, the association between hypertension and ESRD was statistically significant as well (HR, 2.11; 95% CI, 1.05-4.24). Hypertension appears to be associated with a doubling of the risk of future ESRD in an otherwise healthy adolescent population.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007557 Israel A country in the Middle East, bordering the Mediterranean Sea, between Egypt and Lebanon. The capital is Jerusalem.
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D012042 Registries The systems and processes involved in the establishment, support, management, and operation of registers, e.g., disease registers. Parish Registers,Population Register,Parish Register,Population Registers,Register, Parish,Register, Population,Registers, Parish,Registers, Population,Registry
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Adi Leiba, and Boris Fishman, and Gilad Twig, and David Gilad, and Estela Derazne, and Ari Shamiss, and Tamar Shohat, and Ofir Ron, and Ehud Grossman
August 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Adi Leiba, and Boris Fishman, and Gilad Twig, and David Gilad, and Estela Derazne, and Ari Shamiss, and Tamar Shohat, and Ofir Ron, and Ehud Grossman
March 2002, Minerva urologica e nefrologica = The Italian journal of urology and nephrology,
Adi Leiba, and Boris Fishman, and Gilad Twig, and David Gilad, and Estela Derazne, and Ari Shamiss, and Tamar Shohat, and Ofir Ron, and Ehud Grossman
May 1969, The New England journal of medicine,
Adi Leiba, and Boris Fishman, and Gilad Twig, and David Gilad, and Estela Derazne, and Ari Shamiss, and Tamar Shohat, and Ofir Ron, and Ehud Grossman
May 1969, The New England journal of medicine,
Adi Leiba, and Boris Fishman, and Gilad Twig, and David Gilad, and Estela Derazne, and Ari Shamiss, and Tamar Shohat, and Ofir Ron, and Ehud Grossman
December 1998, Kidney international. Supplement,
Adi Leiba, and Boris Fishman, and Gilad Twig, and David Gilad, and Estela Derazne, and Ari Shamiss, and Tamar Shohat, and Ofir Ron, and Ehud Grossman
August 2020, Cureus,
Adi Leiba, and Boris Fishman, and Gilad Twig, and David Gilad, and Estela Derazne, and Ari Shamiss, and Tamar Shohat, and Ofir Ron, and Ehud Grossman
January 2019, Pediatric nephrology (Berlin, Germany),
Adi Leiba, and Boris Fishman, and Gilad Twig, and David Gilad, and Estela Derazne, and Ari Shamiss, and Tamar Shohat, and Ofir Ron, and Ehud Grossman
January 2019, Pediatric nephrology (Berlin, Germany),
Adi Leiba, and Boris Fishman, and Gilad Twig, and David Gilad, and Estela Derazne, and Ari Shamiss, and Tamar Shohat, and Ofir Ron, and Ehud Grossman
September 2015, Advances in medical sciences,
Adi Leiba, and Boris Fishman, and Gilad Twig, and David Gilad, and Estela Derazne, and Ari Shamiss, and Tamar Shohat, and Ofir Ron, and Ehud Grossman
January 2012, Blood purification,
Copied contents to your clipboard!